Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma

24 Nov 2021

Abstract excerpt

BACKGROUND: Pancreatic cancer has been a threateningly lethal malignant tumor worldwide. Despite the promising survival improvement in other cancer types attributing to the fast development of molecular precise medicine, the current treatment situation of pancreatic cancer is still woefully challenging since its limited response to neither traditional radiotherapy and chemotherapy nor emerging immunotherapy. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clusterin in disease pathology
Share to Ferroptosis and cancer prognosis
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34819098
DOI: 10.1186/s12935-021-02324-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinomaPMID 34819098Read ↗

IMUP and GPRC5A: Two Newly Identified Risk Score Indicators in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Identification of a novel immune-related gene prognostic index in pancreatic adenocarcinoma and its implication on tumor immunologySemantic proximity Read ↗

A Novel Immune-Related Gene Prognostic Index (IRGPI) in Pancreatic Adenocarcinoma (PAAD) and Its Implications in the Tumor MicroenvironmentSemantic proximity Read ↗

Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Integrated analysis of multi-omics data to identification of prognostic genes for pancreatic cancerSemantic proximity Read ↗

Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancerSemantic proximity Read ↗

Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.Semantic proximity Read ↗

Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancerSemantic proximity Read ↗

Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.Semantic proximity Read ↗

Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancerSemantic proximity Read ↗

Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.